Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Kano Hiroaki; Kohno, Masakazu; Yasunari, Kenichi; Yokokawa, Koji; Horio, Takeshi; Ikeda, Miwako; Minami, Mieko; Hanehira, Takao; Takeda, Tadanao; Yoshikawa, Junichi
Journal of Hypertension: February 1996
Original Article: Blood Vessels: PDF Only

Objective The present study was designed to examine whether adrenomedullin affects fetal calf serum (FCS) stimulated proliferation in cultured rat vascular smooth muscle cells (VSMCs).

Methods Rat VSMCs were grown from explants of Sprague-Dawley rat aorta and were grown using the standard cell culture method. After incubation for 24 h with various concentrations of adrenomedullin in the presence of 5% FCS, trichloroacetic acid-insoluble tritiated thymidine was measured in a liquid scintillation counter. After incubation for 48 h, cell counts were performed. Cyclic adenosine 3,5-monophosphate (AMP) levels were determined by radioimmunoassay.

Results Rat adrenomedullin exhibited concentration dependent inhibition of the FCS-stimulated increase in thymidine incorporation between 10-7 and 10-9 mol/l and of cell number at 10-7 mol/l. However, the calcitonin generelated peptide (CGRP) receptor antagonist human CGRP(8-37) abolished these antiproliferative effects of rat adrenomedullin. Inhibition by adrenomedullin of FCS-stimulated cellular proliferation was paralleled by an increase in the cellular level of cyclic AMP. 8-Bromocyclic AMP, a cyclic AMP analogue, and forskolin, an activator of adenylate cyclase, inhibited the FCS-stimulated increase in thymidine incorporation and cell number.

Conclusions These results suggst that adrenomedullin inhibits FCS-stimulated proliferation in cultured rat VSMCs, probably through a cyclic AMP-dependent process. Taken together with the finding that adrenomedullin is synthesized in and secreted from vascular endothelial cells, adrenomedullin may play a role as an antiproliferative factor for VSMCs in a paracrine fashion.

© Lippincott-Raven Publishers.